Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Anemia 11Anemia, Iron-Deficiency 6Neoplasms 4Colorectal Neoplasms 4Postoperative Complications 3Pancreatic Neoplasms 2Lymphoproliferative Disorders 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Plexosarcoma 1Ovarian Neoplasms 1Liver Neoplasms 1Inflammatory Breast Neoplasms 1Gastrointestinal Stromal Tumors 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Ductal, Breast 1Cancer Anaemia 1Aortic Aneurysm 1Advanced Gastric Carcinoma 1

Interventions

Paclitaxel 95Carboplatin 76pembrolizumab 72Cisplatin 28Bevacizumab 27Letrozole 22Radiotherapy 21Doxorubicin 21Megestrol Acetate 20lenvatinib 19olaparib 18Taxes 17Docetaxel 17Nivolumab 16Specimen Handling 15Metformin 15dostarlimab 14Magnetic Resonance Spectroscopy 14Gemcitabine 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11Biopsy 11temsirolimus 10abemaciclib 10atezolizumab 9Radiation 9Early Intervention, Educational 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endometrial Neoplasms × ferric carboxymaltose × Clear all
NCT05669872 2023-01-05

Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

Asan Medical Center

Phase NA Unknown
334 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡